Bugao, Anita T.

HRN: 12 75 01  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/21/2023
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
10/21/2023
10/27/2023
PO
5ml
TID
Oral Candidiasis
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Eye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: